Altamira Therapeutics Ltd
NASDAQ:CYTO
Altamira Therapeutics Ltd
Cash from Investing Activities
Altamira Therapeutics Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Altamira Therapeutics Ltd
NASDAQ:CYTO
|
Cash from Investing Activities
CHf1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Novartis AG
SIX:NOVN
|
Cash from Investing Activities
-$5.9B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-104%
|
CAGR 10-Years
-17%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Investing Activities
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Roche Holding AG
SIX:ROG
|
Cash from Investing Activities
-CHf10.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-23%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Altamira Therapeutics Ltd's Cash from Investing Activities?
Cash from Investing Activities
1.4m
CHF
Based on the financial report for Dec 31, 2023, Altamira Therapeutics Ltd's Cash from Investing Activities amounts to 1.4m CHF.